These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 27194043)
1. Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior. Mallick F; McCullumsmith CB Curr Psychiatry Rep; 2016 Jun; 18(6):61. PubMed ID: 27194043 [TBL] [Abstract][Full Text] [Related]
2. Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors. De Berardis D; Fornaro M; Valchera A; Cavuto M; Perna G; Di Nicola M; Serafini G; Carano A; Pompili M; Vellante F; Orsolini L; Fiengo A; Ventriglio A; Yong-Ku K; Martinotti G; Di Giannantonio M; Tomasetti C Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249029 [TBL] [Abstract][Full Text] [Related]
4. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038 [TBL] [Abstract][Full Text] [Related]
5. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial. Grunebaum MF; Galfalvy HC; Choo TH; Keilp JG; Moitra VK; Parris MS; Marver JE; Burke AK; Milak MS; Sublette ME; Oquendo MA; Mann JJ Am J Psychiatry; 2018 Apr; 175(4):327-335. PubMed ID: 29202655 [TBL] [Abstract][Full Text] [Related]
6. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. Wilkinson ST; Ballard ED; Bloch MH; Mathew SJ; Murrough JW; Feder A; Sos P; Wang G; Zarate CA; Sanacora G Am J Psychiatry; 2018 Feb; 175(2):150-158. PubMed ID: 28969441 [TBL] [Abstract][Full Text] [Related]
7. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Price RB; Iosifescu DV; Murrough JW; Chang LC; Al Jurdi RK; Iqbal SZ; Soleimani L; Charney DS; Foulkes AL; Mathew SJ Depress Anxiety; 2014 Apr; 31(4):335-43. PubMed ID: 24668760 [TBL] [Abstract][Full Text] [Related]
8. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547 [TBL] [Abstract][Full Text] [Related]
9. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Murrough JW; Soleimani L; DeWilde KE; Collins KA; Lapidus KA; Iacoviello BM; Lener M; Kautz M; Kim J; Stern JB; Price RB; Perez AM; Brallier JW; Rodriguez GJ; Goodman WK; Iosifescu DV; Charney DS Psychol Med; 2015 Dec; 45(16):3571-80. PubMed ID: 26266877 [TBL] [Abstract][Full Text] [Related]
10. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. Ballard ED; Ionescu DF; Vande Voort JL; Niciu MJ; Richards EM; Luckenbaugh DA; Brutsché NE; Ameli R; Furey ML; Zarate CA J Psychiatr Res; 2014 Nov; 58():161-6. PubMed ID: 25169854 [TBL] [Abstract][Full Text] [Related]
11. A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine. Bloomfield-Clagett B; Ballard ED; Greenstein DK; Wilkinson ST; Grunebaum MF; Murrough JW; Mathew SJ; Phillips JL; Fava M; Sanacora G; Zarate CA Int J Neuropsychopharmacol; 2022 Oct; 25(10):827-838. PubMed ID: 35994774 [TBL] [Abstract][Full Text] [Related]
12. The rapid anti-suicidal ideation effect of ketamine: A systematic review. Hochschild A; Grunebaum MF; Mann JJ Prev Med; 2021 Nov; 152(Pt 1):106524. PubMed ID: 34538369 [TBL] [Abstract][Full Text] [Related]
13. Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches. Al Jurdi RK; Swann A; Mathew SJ Curr Psychiatry Rep; 2015 Oct; 17(10):81. PubMed ID: 26307033 [TBL] [Abstract][Full Text] [Related]
14. Suicide Has Many Faces, So Does Ketamine: a Narrative Review on Ketamine's Antisuicidal Actions. Lengvenyte A; Olié E; Courtet P Curr Psychiatry Rep; 2019 Dec; 21(12):132. PubMed ID: 31797066 [TBL] [Abstract][Full Text] [Related]
15. Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress. Kritzer MD; Mischel NA; Young JR; Lai CS; Masand PS; Szabo ST; Mathew SJ Ann Clin Psychiatry; 2022 Feb; 34(1):33-43. PubMed ID: 35166663 [TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of the effects of ketamine on suicidal ideation in depression patients. Shen Z; Gao D; Lv X; Wang H; Yue W Transl Psychiatry; 2024 Jun; 14(1):248. PubMed ID: 38858391 [TBL] [Abstract][Full Text] [Related]
18. Ketamine Use in Child and Adolescent Psychiatry: Emerging Data in Treatment-Resistant Depression, Insights from Adults, and Future Directions. Ryan K; Hosanagar A Curr Psychiatry Rep; 2023 Aug; 25(8):337-344. PubMed ID: 37389787 [TBL] [Abstract][Full Text] [Related]
19. A Novel Brief Therapy for Patients Who Attempt Suicide: A 24-months Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP). Gysin-Maillart A; Schwab S; Soravia L; Megert M; Michel K PLoS Med; 2016 Mar; 13(3):e1001968. PubMed ID: 26930055 [TBL] [Abstract][Full Text] [Related]
20. Subcutaneous ketamine reduces suicide risk and improves functioning in depression: A proof-of-concept study. Anzolin AP; Baldez DP; Montezano BB; Kapczinski F; de Abreu PB; Kauer-Sant'Anna M Psychiatry Res; 2024 Jul; 337():115915. PubMed ID: 38688118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]